17h00-17h45 Congress registration
17h45-18h00 Opening Ceremony J.Buscombe, A..Signore, A.Hubalewska-Dydejczyk
18h00-18h30 Inaugural IRIST lecture - J. Buscombe (GB): Issues related to
treatment of solid tumours with RIT.
18h30-19h00 Inaugural IRIST lecture – B. Jarzab (PL): Natrium iodide
symporter: a model molecule for targeted therapy.
09h30-10h00 Lecture: M. Lub-de Hooge: ImmunoSPECT and PET in oncology: towards patient tailored therapy.
10h00-10h30 Lecture: Ch.Van de Wiele: Apoptosis imaging in oncology: past and future.
10h30-11h00 Coffee break
Sesion 2: New concepts in radionuclide therapy
Chairmen:
11h00-11h45 Lecture: M. R. Zalutsky (US): Alpha Particle Emitting Radiopharmaceuticals: An Emerging Approach for Targeted Radiotherapy
11h45 -12h15 C.Decristoforo: 68Ga labelling of peptides for clinical applications, trends and Limitations.
12h15 -12h30 Oral 2:
12h30 -12h45 Oral 3:
12h45 - 13:00 Oral 4:
(or 5 shorter oral presentation)
13h00-14h30 Lunch
Poster viewing
14h30 -15h00 Lecture: S. Mather: Setting up a small imaging unit.
15h00 -15h30 Lecture: F. Jamar Dosimetry with radiolabeled peptides
15:30 - 16:00 Lecture: M.Konijnenberg Do the 5 R's of
radiotherapy also apply in radionuclide therapy?
16h00-16h20 Commercial presentation
16h20-17h00 Coffee break
Poster viewing
Session 4: New radiopharmaceutical developments
Chairmen:
17h00-17h30 Lecture: H. Maecke
17h30-17h45 Oral 5:
17h45-18h00 Oral 6: (Or several short presentations )
20h00-late Social Dinner with surprise
Session 5: Radiotherapy strategies
09h00-09h30 Lecture: M. Simmaco Genetic susceptibility to radiosensitivity
09h30-09h45 Oral 7:
09h45-10h00 Oral 8:
10h00-10h15 Oral 9
10h15-10h30 Oral 10 (Or several short presentations )
10h30-11h00 Coffee break
Session 6: Radioimmunotherapy – clinical applications
Chaimen:
11h00 -11h30 Lecture: S. J. Goldsmith Radioimmunotherapy
of Prostate Ca: Current Status of Lu-177 J591 [antiPSMAext]
11h30 -12h00 Lecture: H.Turner: 131I-rituximab radioimmunotherapy of non-Hodgkin lymphoma in 163 patients at a University Hospital
12h00 - 12h15 Oral 11
12h15 - 12h30 Oral 12
12h40 - 12h50 Oral 13
12h50 - 13h00 Oral 14
13h00-14h30 Lunch
Session 7: Radiopeptide imaging and therapy – clinical applications
Chaimen:
14h30-14h45 Lecture A. Hubalewska- Dydejczyk How the somatostatin receptor scintigraphy has changed approach to the patients with neuroendocrine tumours.
14h45-15h15 Lecture H. Turner 177Lu-octreotate radiopeptide therapy of disseminated neuroendocrine tumours with radiosensitizing capecitabine chemotherapy: The CLEMENT Study
15h15-15h30 Oral 14
15h30-15h40 Oral 15
15h40-15h50 Oral 15
15h50 -16h00 Commercial presentation Ibsen
16h00-16h30 Coffee break
General assembly
16h30-17h30
18h00 - Visiting Krakow
Session 8: Nuclear medicine approach to diabetes mellitus
Chairmen:
09h00 - 09h15 Lecture: A. Gilis-Januszewska: The importance of early diagnosis of diabetes
09h15- 09h45 Lecture: A.Signore: Beta-cell imaging for diabetes
9h45 - 09h55 Oral 16
9h55 - 10h05 Oral 17
10h05 - 10h35 Closure Lecture
10h35-11h00 Coffee break
11h30-12h00 Closing ceremony and prize giving
28TH MEETING OF THE INTERNATIONAL SCIENTIFIC COUNCIL FOR TRYPANOSOMIASIS
29 CALIBRATION IN EVERYDAY SCIENTIFIC PRACTICE A CONCEPTUAL FRAMEWORK
2UNIT SYLLABUS SCIENTIFIC WRITING HRP 214 WINTER 2012
Tags: programme, scientific, wednesday, 17h0017h45